134 related articles for article (PubMed ID: 10477727)
1. Signaling via Src family kinases is required for normal internalization of the receptor c-Kit.
Broudy VC; Lin NL; Liles WC; Corey SJ; O'Laughlin B; Mou S; Linnekin D
Blood; 1999 Sep; 94(6):1979-86. PubMed ID: 10477727
[TBL] [Abstract][Full Text] [Related]
2. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
Krystal GW; DeBerry CS; Linnekin D; Litz J
Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
[TBL] [Abstract][Full Text] [Related]
3. The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases.
Tatton L; Morley GM; Chopra R; Khwaja A
J Biol Chem; 2003 Feb; 278(7):4847-53. PubMed ID: 12475982
[TBL] [Abstract][Full Text] [Related]
4. Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells.
Linnekin D; DeBerry CS; Mou S
J Biol Chem; 1997 Oct; 272(43):27450-5. PubMed ID: 9341198
[TBL] [Abstract][Full Text] [Related]
5. Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration.
Ueda S; Mizuki M; Ikeda H; Tsujimura T; Matsumura I; Nakano K; Daino H; Honda Zi Z; Sonoyama J; Shibayama H; Sugahara H; Machii T; Kanakura Y
Blood; 2002 May; 99(9):3342-9. PubMed ID: 11964302
[TBL] [Abstract][Full Text] [Related]
6. Src family kinase activity is required for Kit-mediated mitogen-activated protein (MAP) kinase activation, however loss of functional retinoblastoma protein makes MAP kinase activation unnecessary for growth of small cell lung cancer cells.
Bondzi C; Litz J; Dent P; Krystal GW
Cell Growth Differ; 2000 Jun; 11(6):305-14. PubMed ID: 10910097
[TBL] [Abstract][Full Text] [Related]
7. Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells.
Shivakrupa R; Linnekin D
Cell Signal; 2005 Jan; 17(1):103-9. PubMed ID: 15451030
[TBL] [Abstract][Full Text] [Related]
8. Lyn is activated during late G1 of stem-cell-factor-induced cell cycle progression in haemopoietic cells.
Mou S; Linnekin D
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):163-70. PubMed ID: 10432313
[TBL] [Abstract][Full Text] [Related]
9. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
[TBL] [Abstract][Full Text] [Related]
10. Stat1 associates with c-kit and is activated in response to stem cell factor.
Deberry C; Mou S; Linnekin D
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):73-80. PubMed ID: 9355737
[TBL] [Abstract][Full Text] [Related]
11. Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells.
O'Laughlin-Bunner B; Radosevic N; Taylor ML; Shivakrupa ; DeBerry C; Metcalfe DD; Zhou M; Lowell C; Linnekin D
Blood; 2001 Jul; 98(2):343-50. PubMed ID: 11435302
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Fyn kinase in Kit and integrin-mediated Rac activation, cytoskeletal reorganization, and chemotaxis of mast cells.
Samayawardhena LA; Kapur R; Craig AW
Blood; 2007 May; 109(9):3679-86. PubMed ID: 17213284
[TBL] [Abstract][Full Text] [Related]
13. The tyrosine kinase CSK associates with FLT3 and c-Kit receptors and regulates downstream signaling.
Kazi JU; Vaapil M; Agarwal S; Bracco E; Påhlman S; Rönnstrand L
Cell Signal; 2013 Sep; 25(9):1852-60. PubMed ID: 23707526
[TBL] [Abstract][Full Text] [Related]
14. Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells.
Scappini B; Onida F; Kantarjian HM; Dong L; Verstovsek S; Keating MJ; Beran M
Clin Cancer Res; 2001 Dec; 7(12):3884-93. PubMed ID: 11751479
[TBL] [Abstract][Full Text] [Related]
15. The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling.
Warshamana-Greene GS; Litz J; Buchdunger E; Hofmann F; García-Echeverría C; Krystal GW
Mol Cancer Ther; 2004 May; 3(5):527-35. PubMed ID: 15141010
[TBL] [Abstract][Full Text] [Related]
16. The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction.
Sun J; Pedersen M; Rönnstrand L
J Biol Chem; 2009 Apr; 284(17):11039-47. PubMed ID: 19265199
[TBL] [Abstract][Full Text] [Related]
17. Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells.
van Dijk TB; van Den Akker E; Amelsvoort MP; Mano H; Löwenberg B; von Lindern M
Blood; 2000 Nov; 96(10):3406-13. PubMed ID: 11071635
[TBL] [Abstract][Full Text] [Related]
18. Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells.
Litz J; Krystal GW
Mol Cancer Ther; 2006 Jun; 5(6):1415-22. PubMed ID: 16818499
[TBL] [Abstract][Full Text] [Related]
19. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
Samayawardhena LA; Hu J; Stein PL; Craig AW
Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling.
Liang X; Wisniewski D; Strife A; Shivakrupa ; Clarkson B; Resh MD
J Biol Chem; 2002 Apr; 277(16):13732-8. PubMed ID: 11825908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
